We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.

Necessary Cookies Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics Cookies

We would like to set Google Analytics cookies to help us analyse the traffic on our website.

Acino in Latin America

In 2011, Acino has set up a structure in Panama to serve an increasing demand for high quality pharmaceuticals in Central America. In 2023, the company significantly expanded its presence and capabilities in the region with the acquisition of M8 Pharmaceuticals. This acquisition provided Acino with access to the two largest pharmaceutical markets in Latin America—Mexico and Brazil.

Following the acquisition, Acino established Mexico City as its regional hub, enabling the company to better serve healthcare professionals and patients across the region. In 2024, we enhanced our leadership position in key therapeutic areas with several agreements signed with biopharmaceutical companies to commercialise innovative medicines such as QELBREE®, VORAXAZE®. ZEMIGLO®, ZEMINET® and HYRUAN ONE®.

  • 0

    Sales force employees

  • 0

    Products across Rx and OTC / DTC

  • 0

    Partners

Strategic Partnerships

At Acino, we collaborate with pharmaceutical companies of all sizes, from multinationals to innovative small and medium-sized enterprises, to ensure that patients have access to high-quality medicines. We work with hospitals, pharmacies, and healthcare professionals in Brazil, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Trinidad and Tobago.

Leveraging our market presence and knowledge, our regulatory and commercial expertise, and our world-class distribution capabilities, we help our partners navigate local complexities and bring innovative, proven medicines to those who need them most.

Partner with us to transform healthcare in emerging markets.

* Including “Direct-to-Consumer” product launches.

Leadership Team

Andrés García Baquero

Head of LATAM at Acino and M8, Part of Arcera

Master of Business Administration (MBA) Marketing at Universitat de Lleida

Major in International Marketing Management at Stetson University

  • 2023-25

    Vice-President Sales LATAM at P&G Health

  • 2018-23

    General Manager Mexico at P&G Health

  • 2017-18

    General Manager Mexico & Central America/Caribbean at Merck Group

  • 2013-16

    General Manager Colombia, Ecuador, Venezuela, Perú , Bolivia & Chile at Merck Group

  • 2008-13

    General Manager Genfar Venezuela at Sanofi

Joel Barlan

Advisory Consultant

Rogelio Sandoval

Chief Finantial Officer LATAM at Acino, part of Arcera

Vanessa Escudero

Chief Human Resources Officer LATAM at Acino, part of Arcera

Saulo Xavier

Legal Head LATAM at Acino, part of Arcera

Valentina Martínez Lafeé

Head of Integrity and Compliance LATAM at Acino, part of Arcera

Antonio Sánchez

General Manager Mexico at M8 Pharmaceuticals, part of Arcera

José Luís Lopes

General Manager Brazil at M8 Pharmaceuticals, part of Arcera

Richard Bueno

Managing Director CANDEAN at Acino, part of Arcera

Tales Rabelo

Head of Quality LATAM at Acino, part of Arcera

Alejandro Barrera

Head of Supply Chain LATAM at Acino, part of Arcera